Published June 1992
| Version v1
Journal article
Synthesis of carbon-14 labeled Gadoteridol, [1,4,7-tris(carboxymethyl)-10-(2-hydroxy-1-[14C]propyl)-1.4,7,10-tetraazacyclododecanato]gadolinium
Creators
- 1. Bristol-Myers Squibb Co., Syracuse, NY (United States)
- 2. Bristol-Myers Squibb Co., Wallingford, CT (United States)
Description
Carbon-14 labeled Gadoteridol, [1,4,7-tris(carboxymethyl)-10-(2-hydroxy-1-[14C]propyl)-1,4,7,10-tetraazacyclododecanto] gadolinium, was prepared from 1-[14C]propylene oxide in a total yield of 30.4% and a radiochemical purity of 99.2%. (author)
Additional details
Additional titles
- Augmented title (English)
- NMR imaging contrast agent
Publishing Information
- Journal Title
- Journal of Labelled Compounds and Radiopharmaceuticals
- Journal Volume
- 31
- Journal Issue
- 6
- Journal Page Range
- p. 455-458.
- ISSN
- 0362-4803
- CODEN
- JLCRD4
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- United Kingdom
- INIS RN
- 24005017
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- CARBON 14 COMPOUNDS; CHELATES; CHEMICAL PREPARATION; CONTRAST MEDIA; GADOLINIUM COMPLEXES; LABELLING; NMR IMAGING
- Descriptors DEC
- CARBON COMPOUNDS; COMPLEXES; DIAGNOSTIC TECHNIQUES; RARE EARTH COMPLEXES; SYNTHESIS